Warning letter
DC Nutrition, Inc.: warning letter of Feb 4, 2013
FDA warning letter 336138 · Denver District Office
Key facts
| Reference number | 336138 |
|---|---|
| Company | DC Nutrition, Inc. |
| Subject | CGMP/Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements/Adulterated |
| Issue date | Feb 4, 2013 |
| Posted date | Feb 4, 2013 |
| Issuing office | Denver District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 111.210(g), 101, 101.36, 111, 111.55, 111.83, 111.103, 101.2(e), 101.3(g), 101.4(h)(1), 101.36(e)(1), 111.15(i) and 48 more |
| Inspection city | Wheat Ridge |
| Inspection ZIP | 80033 |
| Inspection start date | Jun 26, 2012 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: